| Dr Asher Johnson, PHD | |
|
480 Alta Rd, San Diego, CA 92179-0001 | |
| (619) 495-2252 | |
| Not Available |
| Full Name | Dr Asher Johnson |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 480 Alta Rd, San Diego, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073876017 | NPI | - | NPPES |
| Entity Name | Access Psychology Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558752931 PECOS PAC ID: 6204155187 Enrollment ID: O20150427000807 |
News Archive
Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).
Today's early morning highlights from the major news organizations, including the latest developments on the Department of Veterans Affairs controversy.
Areas of the brain responsible for pain processing and cognitive performance changed in fibromyalgia patients who exercised following a medication holiday, say researchers from Georgetown University Medical Center. They say the changes indicate brain functioning is more streamlined after an exercise intervention because less of the brain-s resources is devoted to processing bothersome fibromyalgia perceptions such as pain.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). Published online this week in Proceedings of the National Academy of Sciences, the finding may help scientists optimize the drug candidate, PA-824, which targets Mycobacterium tuberculosis (M. tb).
"In a report launched [on Tuesday] - a valuable yardstick called, 'A Growing Opportunity: Measuring Investments in African Agriculture' - ONE reviews the past decade and finds some notable successes in terms of mustering money and political commitment, and the impact of agricultural development," Roger Thurow, senior fellow on global agriculture and food policy at the Chicago Council on Global Affairs, writes in the group's "Global Food For Thought" blog.
› Verified 2 days ago
| Entity Name | Grow Healthcare Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154994846 PECOS PAC ID: 1850774746 Enrollment ID: O20220809004080 |
News Archive
Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).
Today's early morning highlights from the major news organizations, including the latest developments on the Department of Veterans Affairs controversy.
Areas of the brain responsible for pain processing and cognitive performance changed in fibromyalgia patients who exercised following a medication holiday, say researchers from Georgetown University Medical Center. They say the changes indicate brain functioning is more streamlined after an exercise intervention because less of the brain-s resources is devoted to processing bothersome fibromyalgia perceptions such as pain.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). Published online this week in Proceedings of the National Academy of Sciences, the finding may help scientists optimize the drug candidate, PA-824, which targets Mycobacterium tuberculosis (M. tb).
"In a report launched [on Tuesday] - a valuable yardstick called, 'A Growing Opportunity: Measuring Investments in African Agriculture' - ONE reviews the past decade and finds some notable successes in terms of mustering money and political commitment, and the impact of agricultural development," Roger Thurow, senior fellow on global agriculture and food policy at the Chicago Council on Global Affairs, writes in the group's "Global Food For Thought" blog.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Asher Johnson, PHD 480 Alta Rd, San Diego, CA 92179-0001 Ph: () - | Dr Asher Johnson, PHD 480 Alta Rd, San Diego, CA 92179-0001 Ph: (619) 495-2252 |
News Archive
Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).
Today's early morning highlights from the major news organizations, including the latest developments on the Department of Veterans Affairs controversy.
Areas of the brain responsible for pain processing and cognitive performance changed in fibromyalgia patients who exercised following a medication holiday, say researchers from Georgetown University Medical Center. They say the changes indicate brain functioning is more streamlined after an exercise intervention because less of the brain-s resources is devoted to processing bothersome fibromyalgia perceptions such as pain.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). Published online this week in Proceedings of the National Academy of Sciences, the finding may help scientists optimize the drug candidate, PA-824, which targets Mycobacterium tuberculosis (M. tb).
"In a report launched [on Tuesday] - a valuable yardstick called, 'A Growing Opportunity: Measuring Investments in African Agriculture' - ONE reviews the past decade and finds some notable successes in terms of mustering money and political commitment, and the impact of agricultural development," Roger Thurow, senior fellow on global agriculture and food policy at the Chicago Council on Global Affairs, writes in the group's "Global Food For Thought" blog.
› Verified 2 days ago
Dr. Douglas Brackmann, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3101 4th Ave, San Diego, CA 92103 Phone: 858-735-1667 Fax: 619-542-0332 | |
Barton Palmer, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Vasdhs Division Of Geriatric Psychiatry 116a, 3350 La Jolla Village Drive, San Diego, CA 92161 Phone: 858-552-8585 | |
Dr. Lina Kogan-sbarbaro, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1050 University Ave Ste E107, San Diego, CA 92103 Phone: 858-504-7743 Fax: 858-216-1928 | |
Dr. Raymond Peng, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 6540 Lusk Blvd Ste C159, San Diego, CA 92121 Phone: 858-888-9683 | |
Meghan Hammel, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 West Arbor Drive, San Diego, CA 92103 Phone: 619-543-2827 | |
Dr. Rodger Stacy Questin, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 3702 4th Ave, San Diego, CA 92103 Phone: 760-607-7257 | |
Dr. Jessica Lynette Montoya, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 |